Comerica Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.43M | Sell |
19,475
-14,195
| -42% | -$2.32M | 0.01% | 821 |
|
|
2025
Q3 | $4.72M | Buy |
33,670
+12,561
| +60% | +$1.7M | 0.02% | 713 |
|
|
2025
Q2 | $2.65M | Sell |
21,109
-964
| -4% | -$120K | 0.01% | 987 |
|
|
2025
Q1 | $3.02M | Sell |
22,073
-11,623
| -34% | -$1.66M | 0.01% | 909 |
|
|
2024
Q4 | $5.15M | Sell |
33,696
-5,735
| -15% | -$967K | 0.02% | 675 |
|
|
2024
Q3 | $7.64M | Sell |
39,431
-1,467
| -4% | -$307K | 0.03% | 516 |
|
|
2024
Q2 | $9.48M | Sell |
40,898
-1,416
| -3% | -$308K | 0.04% | 417 |
|
|
2024
Q1 | $9.12M | Buy |
42,314
+1,210
| +3% | +$283K | 0.04% | 451 |
|
|
2023
Q4 | $10.6M | Buy |
41,104
+3,025
| +8% | +$743K | 0.05% | 372 |
|
|
2023
Q3 | $9.79M | Buy |
+38,079
| New | +$10.2M | 0.05% | 365 |
|
|
2022
Q4 | $6.93M | Buy |
23,944
+5,949
| +33% | +$1.68M | 0.05% | 417 |
|
|
2022
Q3 | $4.94M | Buy |
17,995
+590
| +3% | +$125K | 0.04% | 512 |
|
|
2022
Q2 | $3.83M | Buy |
17,405
+1,412
| +9% | +$289K | 0.03% | 672 |
|
|
2022
Q1 | $3.52M | Sell |
15,993
-201
| -1% | -$43.7K | 0.03% | 777 |
|
|
2021
Q4 | $3.6M | Sell |
16,194
-5,813
| -26% | -$1.49M | 0.03% | 752 |
|
|
2021
Q3 | $5.83M | Sell |
22,007
-1,671
| -7% | -$548K | 0.04% | 602 |
|
|
2021
Q2 | $8.02M | Sell |
23,678
-1,971
| -8% | -$597K | 0.05% | 449 |
|
|
2021
Q1 | $6.74M | Sell |
25,649
-1,640
| -6% | -$442K | 0.04% | 561 |
|
|
2020
Q4 | $7.35M | Sell |
27,289
-2,437
| -8% | -$629K | 0.05% | 469 |
|
|
2020
Q3 | $7.88M | Sell |
29,726
-935
| -3% | -$261K | 0.06% | 366 |
|
|
2020
Q2 | $8.61M | Sell |
30,661
-1,143
| -4% | -$344K | 0.07% | 295 |
|
|
2020
Q1 | $9.47M | Sell |
31,804
-1,019
| -3% | -$309K | 0.09% | 216 |
|
|
2019
Q4 | $9.11M | Sell |
32,823
-2,275
| -6% | -$631K | 0.07% | 292 |
|
|
2019
Q3 | $10M | Sell |
35,098
-2,859
| -8% | -$666K | 0.08% | 255 |
|
|
2019
Q2 | $8.71M | Sell |
37,957
-3,507
| -8% | -$810K | 0.07% | 298 |
|
|
2019
Q1 | $9.96M | Sell |
41,464
-577
| -1% | -$182K | 0.08% | 246 |
|
|
2018
Q4 | $14.1M | Buy |
42,041
+121
| +0.3% | +$38.6K | 0.12% | 159 |
|
|
2018
Q3 | $13.3M | Sell |
41,920
-13,679
| -25% | -$4.71M | 0.11% | 185 |
|
|
2018
Q2 | $19.7M | Sell |
55,599
-908
| -2% | -$255K | 0.14% | 124 |
|
|
2018
Q1 | $15M | Buy |
56,507
+213
| +0.4% | +$66.1K | 0.11% | 186 |
|
|
2017
Q4 | $19.5M | Sell |
56,294
-2,288
| -4% | -$734K | 0.13% | 138 |
|
|
2017
Q3 | $18.5M | Sell |
58,582
-692
| -1% | -$205K | 0.13% | 135 |
|
|
2017
Q2 | $16.9M | Sell |
59,274
-1,116
| -2% | -$295K | 0.13% | 148 |
|
|
2017
Q1 | $16.7M | Sell |
60,390
-2,067
| -3% | -$584K | 0.13% | 149 |
|
|
2016
Q4 | $17.8M | Buy |
62,457
+1,780
| +3% | +$528K | 0.14% | 136 |
|
|
2016
Q3 | $18.6M | Buy |
60,677
+793
| +1% | +$235K | 0.16% | 120 |
|
|
2016
Q2 | $18.8M | Sell |
59,884
-827
| -1% | -$218K | 0.16% | 120 |
|
|
2016
Q1 | $16.3M | Sell |
60,711
-1,641
| -3% | -$433K | 0.15% | 133 |
|
|
2015
Q4 | $17.5M | Sell |
62,352
-7,582
| -11% | -$2.18M | 0.17% | 106 |
|
|
2015
Q3 | $20.4M | Sell |
69,934
-83,204
| -54% | -$27.5M | 0.19% | 105 |
|
|
2015
Q2 | $61.9M | Buy |
153,138
+74,360
| +94% | +$29.8M | 0.27% | 70 |
|
|
2015
Q1 | $33.3M | Sell |
78,778
-81,906
| -51% | -$32.3M | 0.28% | 64 |
|
|
2014
Q4 | $54.5M | Buy |
160,684
+77,941
| +94% | +$25.2M | 0.24% | 87 |
|
|
2014
Q3 | $27.4M | Sell |
82,743
-6,581
| -7% | -$2.17M | 0.24% | 77 |
|
|
2014
Q2 | $28.2M | Sell |
89,324
-21,446
| -19% | -$6.45M | 0.24% | 84 |
|
|
2014
Q1 | $33.9M | Buy |
110,770
+2,163
| +2% | +$687K | 0.26% | 70 |
|
|
2013
Q4 | $30.4M | Sell |
108,607
-17,449
| -14% | -$4.51M | 0.24% | 77 |
|
|
2013
Q3 | $30.4M | Sell |
126,056
-3,341
| -3% | -$748K | 0.21% | 87 |
|
|
2013
Q2 | $27.8M | Buy |
+129,397
| New | +$27.7M | 0.23% | 80 |
|
Other funds holding BIIB
Comerica Bank's BIIB Position: Q4 2025 in Review
Comerica Bank reduced its Biogen (BIIB) stake by 42% in Q4 2025, selling an estimated $2.32M and leaving 19,475 shares worth $3.43M. The position accounts for 0.01% of the portfolio, ranked #821.
Comerica Bank first reported a position in BIIB in Q2 2013 and has held it in 49 quarters since. The position peaked at $61.9M in Q2 2015. 998 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Comerica Bank held 19,475 shares of Biogen worth $3.43M as of Q4 2025.
- Comerica Bank sold 14,195 Biogen shares in Q4 2025, an estimated $2.32M.
- Biogen made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #821 holding.
- Comerica Bank first reported a position in Biogen in Q2 2013 and has held it in 49 quarters since.
- Comerica Bank's Biogen position peaked at $61.9M in Q2 2015.
- 998 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.